Showing results for "#Drugs Controller General of India"
DGCI issues alert on falsified versions of 2 drugs for cancer, liver...
The DCGI has advised doctors and healthcare professionals to carefully prescribe drugs and educate their patients for reporting any adverse drug...
Serum Institute to launch India's first cervical cancer vaccine
The Drugs Controller General of India granted market authorisation to Serum Institute of India to manufacture the indigenously-developed India's first...
Covid nasal vaccine's phase 3 trials completed: Bharat Biotech chief
India's drug controller had in January this year given permission to Bharat Biotech to conduct standalone phase III trials on its COVID-19 nasal...
DCGI gives emergency use authorisation to Covaxin for 6-12 age group
The DCGI to give emergency use authorisation to Corbevax COVID-19 vaccines for 5-12 age group soon, sources said.
DCGI grants emergency-use approval to single-dose Sputnik Light...
The recommendation was given as the primary dose. Recently, the company submitted a proposal for conducting trials of Sputnik Light as a booster to...
Covaxin granted emergency use listing in 13 nations as on Jan 31...
"Grant of approval to a vaccine by any country is a technical and scientific process for which data is to be submitted to the regulator by the vaccine...
DCGI grants market approval for Covishield, Covaxin, to be available...
DCGI grants conditional market approval for Covishield and Covaxin
India to be hub for Covid-19 anti-viral generic drug: Fitch
Increased access to molnupiravir will keep hospitalisations and deaths in India to a manageable level as Omicron infections rise, Fitch Solutions said...
